Industry: Medical Devices & Consumables
Published Date: 2026-03-15
Pages: 127 Pages
Report ld: 5619571
Request Sample
Customized Report
Nitinol Thrombectomy Stent Market Size(US$)

CAGR 2026-2032
9.5%
Market Size,2032
USD 411
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Nitinol Thrombectomy Stent market was valued at US$ 218 million in 2025 and is anticipated to reach US$ 411 million by 2032, at a CAGR of 9.5% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Nitinol Thrombectomy Stent competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The Nitinol Thrombectomy Stent utilizes the unique superelasticity and shape memory properties of Nitinol to integrate with the thrombus for effective mechanical removal while preserving vessel integrity. Engineered with a highly visible, radiopaque structure and a controlled radial expansion force, this device allows for precise deployment and retrieval within the intricate neurovascular or peripheral vasculature. Its open-cell design facilitates maximum metal-to-thrombus contact to securely engage the occlusion, minimizing the risk of distal embolization and ensuring complete restoration of blood flow. In 2025, global Nitinol Thrombectomy Stent production reached approximately 218 k units with an average global market price of around US$1000 per unit.
As indications expand from acute ischemic stroke to areas such as pulmonary embolism and deep vein thrombosis, the Nitinol Thrombectomy Stent industry is witnessing a significant expansion in market capacity, providing robust momentum for corporate revenue growth. Technological iteration is currently focusing on precision manufacturing and material refinement, aiming to achieve product differentiation by enhancing operational convenience, strengthening radial support, and optimizing delivery system flexibility, thereby maintaining high pricing power and profit margins amidst intense market competition. Simultaneously, the development of specialized stents tailored to different vascular anatomies aligns with the trend of precision medicine, helping enterprises capture high-value market segments. Furthermore, in the face of industry reshaping driven by global healthcare cost containment and normalized centralized procurement, companies with core technological barriers, extensive clinical data, and scalable production capabilities are optimizing cost structures through economies of scale, driving market share toward top-tier players. In the future, the industry will also gradually explore intelligent integration with robotic-assisted surgical systems to adapt to the evolving operating room ecosystem, further solidifying long-term profitability.
This report delivers a comprehensive overview of the global Nitinol Thrombectomy Stent market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Nitinol Thrombectomy Stent. The Nitinol Thrombectomy Stent market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Nitinol Thrombectomy Stent market comprehensively. Regional market sizes by Type, by Application, by Deployment Mechanism, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Nitinol Thrombectomy Stent manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Deployment Mechanism, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Nitinol Thrombectomy Stent manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Nitinol Thrombectomy Stent sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Nitinol Thrombectomy Stent Market Overview
1.1 Product Definition
1.2 Nitinol Thrombectomy Stent by Type
1.2.1 Global Nitinol Thrombectomy Stent Market Value by Type: 2025 vs 2032
1.2.2 Diameter 3MM
1.2.3 Diameter 4MM
1.2.4 Diameter 6MM
1.2.5 Other
1.3 Nitinol Thrombectomy Stent by Deployment Mechanism
1.3.1 Global Nitinol Thrombectomy Stent Market Value by Deployment Mechanism: 2025 vs 2032
1.3.2 Self-expanding Nitinol Stent
1.3.3 Balloon-expandable Stent
1.4 Nitinol Thrombectomy Stent by Material Condition
1.4.1 Global Nitinol Thrombectomy Stent Market Value by Material Condition: 2025 vs 2032
1.4.2 Superelastic Nitinol Stent
1.4.3 Shape Memory Nitinol Stent
1.4.4 Others
1.5 Nitinol Thrombectomy Stent by Application
1.5.1 Global Nitinol Thrombectomy Stent Market Value by Application: 2025 vs 2032
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Global Nitinol Thrombectomy Stent Market Size Estimates and Forecasts
1.6.1 Global Nitinol Thrombectomy Stent Revenue 2021–2032
1.6.2 Global Nitinol Thrombectomy Stent Sales 2021–2032
1.6.3 Global Nitinol Thrombectomy Stent Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Nitinol Thrombectomy Stent Market Competition by Manufacturers
2.1 Global Nitinol Thrombectomy Stent Sales Market Share by Manufacturers (2021–2026)
2.2 Global Nitinol Thrombectomy Stent Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Nitinol Thrombectomy Stent Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Nitinol Thrombectomy Stent, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Nitinol Thrombectomy Stent, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Nitinol Thrombectomy Stent, Product Types and Applications
2.7 Global Key Manufacturers of Nitinol Thrombectomy Stent, Date of Entry into the Industry
2.8 Global Nitinol Thrombectomy Stent Market Competitive Situation and Trends
2.8.1 Global Nitinol Thrombectomy Stent Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Nitinol Thrombectomy Stent Players Market Share by Revenue
2.8.3 Global Nitinol Thrombectomy Stent Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nitinol Thrombectomy Stent Market Scenario by Region
3.1 Global Nitinol Thrombectomy Stent Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Nitinol Thrombectomy Stent Sales by Region: 2021–2032
3.2.1 Global Nitinol Thrombectomy Stent Sales by Region: 2021–2026
3.2.2 Global Nitinol Thrombectomy Stent Sales by Region: 2027–2032
3.3 Global Nitinol Thrombectomy Stent Revenue by Region: 2021–2032
3.3.1 Global Nitinol Thrombectomy Stent Revenue by Region: 2021–2026
3.3.2 Global Nitinol Thrombectomy Stent Revenue by Region: 2027–2032
3.4 North America Nitinol Thrombectomy Stent Market Facts & Figures by Country
3.4.1 North America Nitinol Thrombectomy Stent Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Nitinol Thrombectomy Stent Sales by Country (2021–2032)
3.4.3 North America Nitinol Thrombectomy Stent Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nitinol Thrombectomy Stent Market Facts & Figures by Country
3.5.1 Europe Nitinol Thrombectomy Stent Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Nitinol Thrombectomy Stent Sales by Country (2021–2032)
3.5.3 Europe Nitinol Thrombectomy Stent Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nitinol Thrombectomy Stent Market Facts & Figures by Region
3.6.1 Asia Pacific Nitinol Thrombectomy Stent Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Nitinol Thrombectomy Stent Sales by Region (2021–2032)
3.6.3 Asia Pacific Nitinol Thrombectomy Stent Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nitinol Thrombectomy Stent Market Facts & Figures by Country
3.7.1 Latin America Nitinol Thrombectomy Stent Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Nitinol Thrombectomy Stent Sales by Country (2021–2032)
3.7.3 Latin America Nitinol Thrombectomy Stent Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Nitinol Thrombectomy Stent Market Facts & Figures by Country
3.8.1 Middle East and Africa Nitinol Thrombectomy Stent Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Nitinol Thrombectomy Stent Sales by Country (2021–2032)
3.8.3 Middle East and Africa Nitinol Thrombectomy Stent Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nitinol Thrombectomy Stent Sales by Type (2021–2032)
4.1.1 Global Nitinol Thrombectomy Stent Sales by Type (2021–2026)
4.1.2 Global Nitinol Thrombectomy Stent Sales by Type (2027–2032)
4.1.3 Global Nitinol Thrombectomy Stent Sales Market Share by Type (2021–2032)
4.2 Global Nitinol Thrombectomy Stent Revenue by Type (2021–2032)
4.2.1 Global Nitinol Thrombectomy Stent Revenue by Type (2021–2026)
4.2.2 Global Nitinol Thrombectomy Stent Revenue by Type (2027–2032)
4.2.3 Global Nitinol Thrombectomy Stent Revenue Market Share by Type (2021–2032)
4.3 Global Nitinol Thrombectomy Stent Price by Type (2021–2032)
5 Segment by Application
5.1 Global Nitinol Thrombectomy Stent Sales by Application (2021–2032)
5.1.1 Global Nitinol Thrombectomy Stent Sales by Application (2021–2026)
5.1.2 Global Nitinol Thrombectomy Stent Sales by Application (2027–2032)
5.1.3 Global Nitinol Thrombectomy Stent Sales Market Share by Application (2021–2032)
5.2 Global Nitinol Thrombectomy Stent Revenue by Application (2021–2032)
5.2.1 Global Nitinol Thrombectomy Stent Revenue by Application (2021–2026)
5.2.2 Global Nitinol Thrombectomy Stent Revenue by Application (2027–2032)
5.2.3 Global Nitinol Thrombectomy Stent Revenue Market Share by Application (2021–2032)
5.3 Global Nitinol Thrombectomy Stent Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Nitinol Thrombectomy Stent Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Medtronic Nitinol Thrombectomy Stent Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Acandis
6.2.1 Acandis Company Information
6.2.2 Acandis Description and Business Overview
6.2.3 Acandis Nitinol Thrombectomy Stent Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Acandis Nitinol Thrombectomy Stent Product Portfolio
6.2.5 Acandis Recent Developments/Updates
6.3 TERUMO
6.3.1 TERUMO Company Information
6.3.2 TERUMO Description and Business Overview
6.3.3 TERUMO Nitinol Thrombectomy Stent Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 TERUMO Nitinol Thrombectomy Stent Product Portfolio
6.3.5 TERUMO Recent Developments/Updates
6.4 Stryker
6.4.1 Stryker Company Information
6.4.2 Stryker Description and Business Overview
6.4.3 Stryker Nitinol Thrombectomy Stent Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Stryker Nitinol Thrombectomy Stent Product Portfolio
6.4.5 Stryker Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Company Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Nitinol Thrombectomy Stent Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Johnson & Johnson Nitinol Thrombectomy Stent Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Penumbra
6.6.1 Penumbra Company Information
6.6.2 Penumbra Description and Business Overview
6.6.3 Penumbra Nitinol Thrombectomy Stent Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Penumbra Nitinol Thrombectomy Stent Product Portfolio
6.6.5 Penumbra Recent Developments/Updates
6.7 Phenox
6.7.1 Phenox Company Information
6.7.2 Phenox Description and Business Overview
6.7.3 Phenox Nitinol Thrombectomy Stent Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Phenox Nitinol Thrombectomy Stent Product Portfolio
6.7.5 Phenox Recent Developments/Updates
6.8 Rapid Medical
6.8.1 Rapid Medical Company Information
6.8.2 Rapid Medical Description and Business Overview
6.8.3 Rapid Medical Nitinol Thrombectomy Stent Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Rapid Medical Nitinol Thrombectomy Stent Product Portfolio
6.8.5 Rapid Medical Recent Developments/Updates
6.9 Furukawa
6.9.1 Furukawa Company Information
6.9.2 Furukawa Description and Business Overview
6.9.3 Furukawa Nitinol Thrombectomy Stent Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Furukawa Nitinol Thrombectomy Stent Product Portfolio
6.9.5 Furukawa Recent Developments/Updates
6.10 Shandong Weigao Group Medical Polymer Company
6.10.1 Shandong Weigao Group Medical Polymer Company Company Information
6.10.2 Shandong Weigao Group Medical Polymer Company Description and Business Overview
6.10.3 Shandong Weigao Group Medical Polymer Company Nitinol Thrombectomy Stent Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Shandong Weigao Group Medical Polymer Company Nitinol Thrombectomy Stent Product Portfolio
6.10.5 Shandong Weigao Group Medical Polymer Company Recent Developments/Updates
6.11 Shanghai Skynor Medical
6.11.1 Shanghai Skynor Medical Company Information
6.11.2 Shanghai Skynor Medical Description and Business Overview
6.11.3 Shanghai Skynor Medical Nitinol Thrombectomy Stent Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Shanghai Skynor Medical Nitinol Thrombectomy Stent Product Portfolio
6.11.5 Shanghai Skynor Medical Recent Developments/Updates
6.12 HeMo Bioengineering
6.12.1 HeMo Bioengineering Company Information
6.12.2 HeMo Bioengineering Description and Business Overview
6.12.3 HeMo Bioengineering Nitinol Thrombectomy Stent Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 HeMo Bioengineering Nitinol Thrombectomy Stent Product Portfolio
6.12.5 HeMo Bioengineering Recent Developments/Updates
6.13 Suzhou Zenith Vascular Scitech
6.13.1 Suzhou Zenith Vascular Scitech Company Information
6.13.2 Suzhou Zenith Vascular Scitech Description and Business Overview
6.13.3 Suzhou Zenith Vascular Scitech Nitinol Thrombectomy Stent Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Suzhou Zenith Vascular Scitech Nitinol Thrombectomy Stent Product Portfolio
6.13.5 Suzhou Zenith Vascular Scitech Recent Developments/Updates
6.14 Shanghai HeartCare Medical Technology Corporations
6.14.1 Shanghai HeartCare Medical Technology Corporations Company Information
6.14.2 Shanghai HeartCare Medical Technology Corporations Description and Business Overview
6.14.3 Shanghai HeartCare Medical Technology Corporations Nitinol Thrombectomy Stent Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Shanghai HeartCare Medical Technology Corporations Nitinol Thrombectomy Stent Product Portfolio
6.14.5 Shanghai HeartCare Medical Technology Corporations Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nitinol Thrombectomy Stent Industry Chain Analysis
7.2 Nitinol Thrombectomy Stent Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nitinol Thrombectomy Stent Production Mode & Process Analysis
7.4 Nitinol Thrombectomy Stent Sales and Marketing
7.4.1 Nitinol Thrombectomy Stent Sales Channels
7.4.2 Nitinol Thrombectomy Stent Distributors
7.5 Nitinol Thrombectomy Stent Customer Analysis
8 Nitinol Thrombectomy Stent Market Dynamics
8.1 Nitinol Thrombectomy Stent Industry Trends
8.2 Nitinol Thrombectomy Stent Market Drivers
8.3 Nitinol Thrombectomy Stent Market Challenges
8.4 Nitinol Thrombectomy Stent Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Nitinol Thrombectomy Stent market is projected to grow from US$ 218 million in 2025 to US$ 411 million by 2032, at a CAGR of 9.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 155
USD 4900.00
(Single User License)
The global Nitinol Thrombectomy Stent market size was US$ 218 million in 2025 and is forecast to reach a readjusted size of US$ 411 million by 2032 with a CAGR of 9.5% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 97
USD 4250.00
(Single User License)
The global market for Nitinol Thrombectomy Stent was estimated to be worth US$ 218 million in 2025 and is projected to reach US$ 411 million, growing at a CAGR of 9.5% from 2026 to 2032.
Published Date: 2026-03-15
Pages: 121
USD 3950.00
(Single User License)
The global Nitinol Thrombectomy Stent market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 175
USD 4900.00
(Single User License)
The global Nitinol Thrombectomy Stent market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 108
USD 4250.00
(Single User License)
The global market for Nitinol Thrombectomy Stent was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 137
USD 3950.00
(Single User License)
The global market for Nitinol Thrombectomy Stent was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 100
USD 2900.00
(Single User License)
Nitinol thrombectomy stent is a medical device used for removing blood clots from vessels, primarily made of nitinol alloy. The stent has excellent flexibility and shape memory, allowing it to conform to the vessel's shape. Once deployed inside the vessel, it can capture and remove the clot, commonly used for treating acute ischemic stroke and peripheral vascular diseases.
Published Date: 2024-10-10
Pages: 146
USD 4350.00
(Single User License)
Nitinol thrombectomy stent is a medical device used for removing blood clots from vessels, primarily made of nitinol alloy. The stent has excellent flexibility and shape memory, allowing it to conform to the vessel's shape. Once deployed inside the vessel, it can capture and remove the clot, commonly used for treating acute ischemic stroke and peripheral vascular diseases.
Published Date: 2024-10-10
Pages: 182
USD 4900.00
(Single User License)
Nitinol thrombectomy stent is a medical device used for removing blood clots from vessels, primarily made of nitinol alloy. The stent has excellent flexibility and shape memory, allowing it to conform to the vessel's shape. Once deployed inside the vessel, it can capture and remove the clot, commonly used for treating acute ischemic stroke and peripheral vascular diseases.
Published Date: 2024-10-10
Pages: 140
USD 3950.00
(Single User License)
The global Nitinol Thrombectomy Stent market is projected to grow from US$ 218 million in 2025 to US$ 411 million by 2032, at a CAGR of 9.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 155
The global Nitinol Thrombectomy Stent market size was US$ 218 million in 2025 and is forecast to reach a readjusted size of US$ 411 million by 2032 with a CAGR of 9.5% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 97
The global market for Nitinol Thrombectomy Stent was estimated to be worth US$ 218 million in 2025 and is projected to reach US$ 411 million, growing at a CAGR of 9.5% from 2026 to 2032.
Published: 2026-03-15
Pages: 121
The global Nitinol Thrombectomy Stent market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 175
The global Nitinol Thrombectomy Stent market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 108
The global market for Nitinol Thrombectomy Stent was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 137
The global market for Nitinol Thrombectomy Stent was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 100
Nitinol thrombectomy stent is a medical device used for removing blood clots from vessels, primarily made of nitinol alloy. The stent has excellent flexibility and shape memory, allowing it to conform to the vessel's shape. Once deployed inside the vessel, it can capture and remove the clot, commonly used for treating acute ischemic stroke and peripheral vascular diseases.
Published: 2024-10-10
Pages: 146
Nitinol thrombectomy stent is a medical device used for removing blood clots from vessels, primarily made of nitinol alloy. The stent has excellent flexibility and shape memory, allowing it to conform to the vessel's shape. Once deployed inside the vessel, it can capture and remove the clot, commonly used for treating acute ischemic stroke and peripheral vascular diseases.
Published: 2024-10-10
Pages: 182
Nitinol thrombectomy stent is a medical device used for removing blood clots from vessels, primarily made of nitinol alloy. The stent has excellent flexibility and shape memory, allowing it to conform to the vessel's shape. Once deployed inside the vessel, it can capture and remove the clot, commonly used for treating acute ischemic stroke and peripheral vascular diseases.
Published: 2024-10-10
Pages: 140
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now